Search

Search Results

• Should anti-CGRP monoclonal antibodies always be the drug of first choice for migraine prophylaxis in Brazil? - a pharmacoeconomic study

  Davy Henrique Sousa Pelliciari, Caio Ricco Alves Reis, Carlos Alberto Bordini (Author)

  170-174

  2024-09-30

  
  Views: 949
  

  DOI: https://doi.org/10.48208/HeadacheMed.2024.34

• CGRP: from history to clinical application - A review

  Afonso Henrique Aragao, Joel Sanabria Duarte, Daniel Benzecry Almeida, Ricardo Ramina (Author)

  61-67

  2020-09-30

  
  Views: 600
  

  DOI: https://doi.org/10.48208/HeadacheMed.2020.18